GLP-1 wave to redraw India's consumption: snacking down 40-60%, protein and skincare up
Marketer Jahnavi Jain warns Ozempic-Wegovy adoption could shrink appetites 30% and capture 35% of F&B spend by 2030. Kirana snacks, QSRs, sugary drinks and thali platters lose ground to high-protein mini-meals, electrolytes and firming skincare. Premium urban Indians seen adopting within two years.
Marketer Jahnavi Jain says GLP-1 weight-loss drugs will reshape consumption: high-protein mini meals, firming skincare, electrolyte beverages rise; kirana snacks, QSRs, sugary drinks, thali platters suffer. Premium urban Indian consumers likely early adopters within two years.
Why this matters
Signal reframes India's FMCG playbook: kirana snacks, QSRs, sugary drinks and thali platters face structural demand loss as weight-loss drugs reach affluent urban cohorts within two years.
Retail-brand theme steady at 252 signals over 90 days, with GLP-1 disruption emerging as a category-redrawing force.